Equities

EUDA Health Holdings Ltd

EUDA:NAQ

EUDA Health Holdings Ltd

Actions
Health CareHealth Care Providers
  • Price (USD)3.43
  • Today's Change-0.21 / -5.77%
  • Shares traded11.00
  • 1 Year change+125.66%
  • Beta--
Data delayed at least 15 minutes, as of Sep 19 2024 20:59 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year EUDA Health Holdings Ltd had relatively flat revenues (3.76m to 3.71m), though the company grew net income from a loss of 24.88m to a smaller loss of 10.04m. A reduction in the selling, general and administrative costs as a percentage of sales from 317.25% to 129.37% was a component in the net income growth despite flat revenues.
Gross margin22.72%
Net profit margin-227.57%
Operating margin-124.29%
Return on assets-62.62%
Return on equity--
Return on investment--
More ▼

Cash flow in USDView more

In 2023, cash reserves at EUDA Health Holdings Ltd fell by 586.94k. Cash Flow from Financing totalled 2.35m or 63.47% of revenues. In addition the company used 2.92m for operations while cash from investing was breakeven.
Cash flow per share-0.1108
Price/Cash flow per share--
Book value per share-0.3045
Tangible book value per share-0.3045
More ▼

Balance sheet in USDView more

EUDA Health Holdings Ltd uses little or no debt in its capital structure.
Current ratio0.083
Quick ratio--
Total debt/total equity--
Total debt/total capital--
More ▼

Growth rates in USD

Year on year, growth in earnings per share excluding extraordinary items increased 55.38%.
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago
--
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.